Literature DB >> 32804489

Pathway-Guided Deep Neural Network toward Interpretable and Predictive Modeling of Drug Sensitivity.

Lei Deng1, Yideng Cai1, Wenhao Zhang2, Wenyi Yang1, Bo Gao3, Hui Liu2.   

Abstract

To efficiently save cost and reduce risk in drug research and development, there is a pressing demand to develop in silico methods to predict drug sensitivity to cancer cells. With the exponentially increasing number of multi-omics data derived from high-throughput techniques, machine learning-based methods have been applied to the prediction of drug sensitivities. However, these methods have drawbacks either in the interpretability of the mechanism of drug action or limited performance in modeling drug sensitivity. In this paper, we presented a pathway-guided deep neural network (DNN) model to predict the drug sensitivity in cancer cells. Biological pathways describe a group of molecules in a cell that collaborates to control various biological functions like cell proliferation and death, thereby abnormal function of pathways can result in disease. To take advantage of the excellent predictive ability of DNN and the biological knowledge of pathways, we reshaped the canonical DNN structure by incorporating a layer of pathway nodes and their connections to input gene nodes, which makes the DNN model more interpretable and predictive compared to canonical DNN. We have conducted extensive performance evaluations on multiple independent drug sensitivity data sets and demonstrated that our model significantly outperformed the canonical DNN model and eight other classical regression models. Most importantly, we observed a remarkable activity decrease in disease-related pathway nodes during forward propagation upon inputs of drug targets, which implicitly corresponds to the inhibition effect of disease-related pathways induced by drug treatment on cancer cells. Our empirical experiments showed that our method achieves pharmacological interpretability and predictive ability in modeling drug sensitivity in cancer cells. The web server, the processed data sets, and source codes for reproducing our work are available at http://pathdnn.denglab.org.

Entities:  

Year:  2020        PMID: 32804489     DOI: 10.1021/acs.jcim.0c00331

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  3 in total

1.  Multiple Laplacian Regularized RBF Neural Network for Assessing Dry Weight of Patients With End-Stage Renal Disease.

Authors:  Xiaoyi Guo; Wei Zhou; Yan Yu; Yinghua Cai; Yuan Zhang; Aiyan Du; Qun Lu; Yijie Ding; Chao Li
Journal:  Front Physiol       Date:  2021-12-13       Impact factor: 4.566

2.  Classification and Functional Analysis between Cancer and Normal Tissues Using Explainable Pathway Deep Learning through RNA-Sequencing Gene Expression.

Authors:  Sangick Park; Eunchong Huang; Taejin Ahn
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

3.  Risk stratification and pathway analysis based on graph neural network and interpretable algorithm.

Authors:  Bilin Liang; Haifan Gong; Lu Lu; Jie Xu
Journal:  BMC Bioinformatics       Date:  2022-09-27       Impact factor: 3.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.